These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33452633)

  • 1. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study.
    Kas A; Soret M; Pyatigoskaya N; Habert MO; Hesters A; Le Guennec L; Paccoud O; Bombois S; Delorme C;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2543-2557. PubMed ID: 33452633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings.
    Delorme C; Paccoud O; Kas A; Hesters A; Bombois S; Shambrook P; Boullet A; Doukhi D; Le Guennec L; Godefroy N; Maatoug R; Fossati P; Millet B; Navarro V; Bruneteau G; Demeret S; Pourcher V;
    Eur J Neurol; 2020 Dec; 27(12):2651-2657. PubMed ID: 32881133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study.
    Sollini M; Morbelli S; Ciccarelli M; Cecconi M; Aghemo A; Morelli P; Chiola S; Gelardi F; Chiti A
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3187-3197. PubMed ID: 33677642
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Guedj E; Campion JY; Dudouet P; Kaphan E; Bregeon F; Tissot-Dupont H; Guis S; Barthelemy F; Habert P; Ceccaldi M; Million M; Raoult D; Cammilleri S; Eldin C
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2823-2833. PubMed ID: 33501506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19.
    Ferrucci R; Cuffaro L; Capozza A; Rosci C; Maiorana N; Groppo E; Reitano MR; Poletti B; Ticozzi N; Tagliabue L; Silani V; Priori A
    J Neurol; 2023 Apr; 270(4):1823-1834. PubMed ID: 36692636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in 18F-FDG PET/MRI and 15O-Water PET Brain Findings in Patients With Neurological Symptoms After COVID-19 Vaccination: A Pilot Study.
    Siripongsatian D; Kunawudhi A; Promteangtrong C; Kiatkittikul P; Jantarato A; Choolam A; Ponglikitmongkol K; Siripongboonsitti T; Kaeowirun T; Chotipanich C
    Clin Nucl Med; 2022 Mar; 47(3):e230-e239. PubMed ID: 35025789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-COVID-19 Brain [
    Debs P; Khalili N; Solnes L; Al-Zaghal A; Sair HI; Yedavalli V; Luna LP
    AJNR Am J Neuroradiol; 2023 May; 44(5):517-522. PubMed ID: 37105680
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Guedj E; Million M; Dudouet P; Tissot-Dupont H; Bregeon F; Cammilleri S; Raoult D
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):592-595. PubMed ID: 32728799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [
    Sollini M; Ciccarelli M; Cecconi M; Aghemo A; Morelli P; Gelardi F; Chiti A
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1460-1466. PubMed ID: 33123760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual interpretation of brain hypometabolism related to neurological long COVID: a French multicentric experience.
    Verger A; Kas A; Dudouet P; Goehringer F; Salmon-Ceron D; Guedj E
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3197-3202. PubMed ID: 35320385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory response in lungs and extrapulmonary sites detected by [
    Bai Y; Xu J; Chen L; Fu C; Kang Y; Zhang W; Fakhri GE; Gu J; Shao F; Wang M
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2531-2542. PubMed ID: 33420914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report of 18F-FDG PET/CT features of hypoglycemic encephalopathy.
    Shen XZ; Zhang YX; You QY
    Medicine (Baltimore); 2023 Jun; 102(24):e34025. PubMed ID: 37327258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients.
    Morassi M; Palmerini F; Nici S; Magni E; Savelli G; Guerra UP; Chieregato M; Morbelli S; Vogrig A
    J Neurol; 2021 Nov; 268(11):3980-3987. PubMed ID: 33884450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease.
    Tondo G; Iaccarino L; Caminiti SP; Presotto L; Santangelo R; Iannaccone S; Magnani G; Perani D
    Alzheimers Res Ther; 2020 Apr; 12(1):50. PubMed ID: 32354345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in brain glucose metabolism and connectivity in somatoform disorders: an
    Huang Q; Ren S; Jiang D; Guan Y; Xie F; Sun D; Hua F
    Eur Arch Psychiatry Clin Neurosci; 2020 Oct; 270(7):881-891. PubMed ID: 31720787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 in the act: incidental 18F-FDG PET/CT findings in asymptomatic patients and those with symptoms not primarily correlated with COVID-19 during the United Kingdom coronavirus lockdown.
    Halsey R; Priftakis D; Mackenzie S; Wan S; Davis LM; Lilburn D; Thornton A; Papathanasiou N; Gnanasegaran G; Bomanji J
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):269-281. PubMed ID: 32761260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms.
    Rau A; Schroeter N; Blazhenets G; Dressing A; Walter LI; Kellner E; Bormann T; Mast H; Wagner D; Urbach H; Weiller C; Meyer PT; Reisert M; Hosp JA
    Brain; 2022 Sep; 145(9):3203-3213. PubMed ID: 35675908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.